Thermedical scores $5.5M in funding for tumor, heart ablation research

Massachusetts-based devicemaker Thermedical secured $5.5 million to hire additional staff and advance research in ablation for solid tumors and ventricular tachycardia, a dangerous arrhythmia of the heart, bringing the company's total first round of financing to $7 million. The FDA-cleared radio frequency thermal ablation system injects hot saline into the affected area to treat large amounts of tissue, according to a Mass High Tech report. Thermedical will begin human trials later this year. More

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.